PDS Biotech Announces the Publication of PDS0301 Study Linking Induced Changes in Immune Responses with Clinical Outcomes in International Immunopharmacology Journal
March 01, 2023 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., March 01, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium
October 12, 2022 07:30 ET
|
Theratechnologies
MONTREAL, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
Theratechnologies présente des données démontrant la surexpression de la sortiline (SORT1) dans plusieurs types de tumeurs au 34e symposium de l’EORTC-NCI-AACR
October 12, 2022 07:30 ET
|
Theratechnologies
MONTRÉAL, 12 oct. 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou « la Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au...
INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT
June 16, 2022 09:00 ET
|
Invectys, Inc.
HOUSTON, June 16, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. (Invectys), The University of Texas MD Anderson Cancer Center and the Cell Therapy Manufacturing Center (CTMC), a joint venture between...
New Gadolinium-Free MRI Contrast Agent Advances Safer Patient Care
June 13, 2022 10:00 ET
|
Reveal Pharmaceuticals
CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate in the brain and body of every patient,...
LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES THAT ENROLLMENT HAS RESUMED IN NATIONAL CANCER INSTITUTE’S TRIAL TO DETERMINE ABILITY OF LIXTE COMPOUND LB-100 TO ENTER RECURRENT, MALIGNANT BRAIN TUMORS
November 22, 2021 09:25 ET
|
Lixte Biotechnology Holdings, Inc.
PASADENA, CA, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) announced that the National Cancer Institute (NCI) has resumed enrolling patients into their...
Refrigeration Control Company, Inc. Launches Their New Website
December 02, 2020 15:41 ET
|
Refrigeration Control Company Inc
Centerville, Ohio - (Dayton and Cincinnati), Dec. 02, 2020 (GLOBE NEWSWIRE) -- Since 1979, Refrigeration Control Company, Inc. has served commercial partners across Ohio, Kentucky and Indiana and...
National Cancer Institute (NCI) Extends Long-Standing Partnership with Inspirata
September 29, 2020 10:26 ET
|
Inspirata, Inc.
Tampa, Florida, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Inspirata announced today the renewal of its long-standing partnership with the National Cancer Institute (NCI). Building on almost two decades of...
The Best Thanksgiving
November 26, 2019 17:59 ET
|
The Children's Inn at NIH
Bethesda, Maryland, Nov. 26, 2019 (GLOBE NEWSWIRE) -- One Texas family has lots to be thankful for this Thanksgiving. Their daughter, now 13, is doing well after undergoing a bone marrow...
EEI, MBCQ, MAMS, and NCI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
September 16, 2019 13:19 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Ecology & Environment Inc. (NASDAQ GS: EEI) regarding possible breaches of...